ArticleAmerican journal of cancer research2016

Therapeutic evaluation of monoclonal antibody-maytansinoid conjugate as a model of RON-targeted drug delivery for pancreatic cancer treatment.

Hang-Ping Yao et al.PubMed ↗Full text ↗

No numbers read from the abstract.